The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.EBI
University Jena
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.EBI
National Institutes Of Health
Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase.EBI
University Of Salerno
Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes.EBI
University Of California Santa Cruz
Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases.EBI
University Of California Santa Cruz
Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries.EBI
University Of California
Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase.EBI
University Of California
Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils.EBI
Gazi University
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.EBI
National Human Genome Research Institute
Natural compound cudraflavone B shows promising anti-inflammatory properties in vitro.EBI
University Of Veterinary And Pharmaceutical Sciences Brno
Potent and selective 5-LO inhibitor bearing benzothiophene pharmacophore: discovery of MK-5286.EBI
Merck Frosst Centre For Therapeutic Research
Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.EBI
National Human Genome Research Institute
 
Catechol based inhibitors of 15-lipoxygenaseEBI
TBA
 
1-Phenyl-[2H]-tetrahydropyridazin-3-one, A-53612, a selective orally active 5-lipoxygenase inhibitorEBI
TBA
An analysis of phakellin and oroidin structures stimulated by further study of an Agelas sponge.EBI
University Of California
Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.EBI
Universidad De Santiago De Chile
Novel human lipoxygenase inhibitors discovered using virtual screening with homology models.EBI
University Of California
Probing the activity differences of simple and complex brominated aryl compounds against 15-soybean, 15-human, and 12-human lipoxygenase.EBI
University Of California
5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.EBI
Abbott Laboratories
Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.EBI
Ciba-Geigy